Kim L. O'Neill is the developer of a monoclonal antibody that allows for the accurate, cheap and easy detection of cancer.
O'Neill has a B.Sc. degree from New University of Ulster and a Ph.D. from the University of Ulster. He is a professor of microbiology at Brigham Young University.
O'Neill is also a convert to The Church of Jesus Christ of Latter-day Saints, having joined the church in Ireland.